Back To: Home : Featured Technology : Flow Cytometry

CLICK HERE FOR WHAT'S NEW IN:
 

Thermo begins groundbreaking protein biomarker project with George Mason University
July 2008
SHARING OPTIONS:

WALTHAM, Mass.—In a collaboration aimed at accelerating verification and validation of protein biomarkers for earlier disease diagnosis and therapeutic efficacy, Thermo Fisher Scientific Inc. recently announced an alliance between its Biomarker Research Initiatives in Mass Spectrometry (BRIMS) Center and George Mason University's Center for Applied Proteomics and Molecular Medicine (CAPMM).

A key challenge in biomarker research has been independent validation of experimental results. The alliance between Thermo Fisher and CAPMM will overcome this challenge by creating a unique "cross-validation" workflow between the BRIMS and the George Mason University laboratory to provide fast biomarker validation. Both labs will use identical Thermo Scientific Quantum Ultra triple quadrupole mass spectrometers to analyze assays. After a newly discovered biomarker has been validated in the CAPMM lab, it will be sent to the BRIMS lab in Boston for independent validation.

 

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.